massively parallel sequencing Illumina Sequencing Instrument Sales, COVID-19 Surveillance Continue to Boost Business Premium The sequencing technology company saw improved sales in all instrument categories, from its smaller benchtop sequencers to its highest-throughput ones. PacBio's Omniome Acquisition Aims to Shorten Path to Clinical Testing Market Premium PacBio's acquisition of Omniome, worth up to $800 million, could give it access to lucrative applications in short-read sequencing, including oncology and noninvasive prenatal testing. Illumina, Sanigen Partner on NGS-Based Food Safety Testing in South Korea As part of the agreement, Sanigen will distribute Illumina's next-generation sequencing platforms in South Korea for the food safety and microbiology testing market. New Haplotagging Method Offers Low-Cost Phasing, Genome Scaffolding With Short-Read Sequencing Premium Sample prep for low-coverage Illumina sequencing can be done in less than two days and for less than $2 per library, according to the developers. JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems Analysts estimated the total addressable market for the San Diego-based next-generation sequencing firm at between $44 billion and $50 billion. Jun 14, 2021 Twist Bioscience, Regeneron Genetics Center Codevelop NGS Genotyping Panel for Population Sequencing May 28, 2021 Global Subway Metagenomics Study Reveals Cities' Microbial Fingerprints May 28, 2021 New Oxford Nanopore Sequencing Chemistry Reaches 99 Percent Accuracy for Many Reads Premium May 27, 2021 Singular Genomics Systems Raises $258M in Upsized IPO May 12, 2021 Sequencing Startup Singular Genomics Files for $100M IPO May 4, 2021 Verogen, Eurofins Partner to Implement NGS-Based Forensics Apr 28, 2021 Illumina Touts Participation in Global Pathogen, Population Sequencing Initiatives Premium Apr 20, 2021 European Union to Review Illumina's Planned Grail Acquisition Under New Guidance Apr 8, 2021 Long-Read Genome Assemblies Have 'Blind Spots' for Structural Variant Detection Premium Apr 2, 2021 Illumina Parries FTC Challenge to Grail Acquisition With Deals for Competing Customers Premium Mar 30, 2021 FTC Moves to Block Illumina's $8B Grail Acquisition Mar 29, 2021 Armonica Technologies Wins $349K SBIR Grant From NHGRI Mar 24, 2021 Twist Bioscience, Biotia Nab FDA EUA for Hybridization-Based NGS SARS-CoV-2 Assay Mar 16, 2021 Illumina, Geneseeq Technology to Collaborate on IVD Cancer Testing Kits in China Mar 8, 2021 Illumina Inks $750M Credit Facility With Bank of America Feb 26, 2021 New Method Provides NGS-Based Readout of Glycan Levels in Single Cells Premium Feb 25, 2021 Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch Premium Feb 24, 2021 Adaptive Biotechnologies Q4 Revenues Rise 25 Percent Feb 22, 2021 Twist Bioscience, Berry Genomics Partner on Targeted NGS Assays in China Feb 16, 2021 Fulgent Genetics, BioIQ Partner on NGS-Based SARS-CoV-2 Variant Detection Load More Breaking News IV BioHoldings Partners With P4 Diagnostix, Unveils 'Bio Innovation Studio' Polynesian Island Population History Revealed From Present-Day Human Genomes Aviv Scientific Closes $40M Series B Financing Round Roche Nabs CE Mark for Three Cobas Respiratory Test Panels Hexagon Bio Raises $61M in Private Financing Round GenXys, Helix Partner to Provide Clinical Decision Support for PGx Testing The Scan Not Yet a Permanent One NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials. Unfair Targeting Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases. Limited Rapid Testing The New York Times wonders why rapid tests for COVID-19 are not widely available in the US. Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.